Testing tears as a way to track glioblastoma
Original title: Tear Fluid for the Detection of Tumor-associated Extracellular Vesicles in Glioblastoma Patients
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This study does not list a phase, and it is still a test in people.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study checks if tears hold tiny particles that carry news about a brain tumor.
Who this trial is for. This trial is for people with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, a type of brain tumor. It tests whether tear fluid can show the tiny tumor particles that are found in spinal fluid.
Where it stands. The trial is measuring whether tears carry the same kind of tumor particles. Spinal fluid is hard and costly to collect, and tears are easier. Whether tears work as well is the open question. The trial has not reported results.
What this means, and what it doesn't
What it could mean: If tears can show these particles, checking a tumor over time could get easier. That is not known yet. Someone with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary who is interested could ask their care team about this study.
What it doesn't mean: This does not mean tears can track a brain tumor today. A trial is a test, not a proven treatment. Joining a study is not a promise that it will help you. This is not a cure, and it is not a treatment at all. It is a way of looking for information.
Source: ClinicalTrials.gov, August 20, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.